Literature DB >> 15820858

Effects of multiple exposures to D-cycloserine on extinction of conditioned fear in rats.

A Sophie Parnas1, Marianne Weber, Rick Richardson.   

Abstract

Previous research has shown that an acute, post-training injection of D-cycloserine (DCS) facilitates extinction of conditioned fear in rats; however, the effects of multiple exposures to DCS in this situation are not known. In Experiment 1, rats were conditioned (light-shock pairings) and 24 h later given six extinction (light-alone) trials followed by an injection of DCS (15 mg/kg) or saline. The next day, all rats were tested for light-elicited freezing. In Experiment 2, the effect of DCS on extinction was tested in the same manner, except that rats were pre-exposed to DCS (0, 1, or 5 injections) just prior to conditioning. In Experiment 3, rats received five pre-exposures of DCS but conditioning occurred either 2 or 28 days after the last pre-exposure. The results showed that DCS facilitated extinction of conditioned freezing to the light CS when no drug pre-exposure had occurred, but pre-exposure to DCS just prior to conditioning disrupted the facilitation of extinction effect. When 28 days were interposed between pre-exposure and conditioning, the facilitatory effects of DCS on extinction were restored. These findings suggest that DCS has significant clinical value but that behavioral desensitization may occur with multiple exposures; however, desensitization is not permanent and is reduced by the passage of time.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15820858     DOI: 10.1016/j.nlm.2005.01.001

Source DB:  PubMed          Journal:  Neurobiol Learn Mem        ISSN: 1074-7427            Impact factor:   2.877


  68 in total

Review 1.  Pharmacological enhancement of drug cue extinction learning: translational challenges.

Authors:  K M Kantak; B Á Nic Dhonnchadha
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

Review 2.  The treatment of cognitive impairment in schizophrenia.

Authors:  Donald C Goff; Michele Hill; Deanna Barch
Journal:  Pharmacol Biochem Behav       Date:  2010-11-27       Impact factor: 3.533

Review 3.  Enhancement of Psychosocial Treatment With D-Cycloserine: Models, Moderators, and Future Directions.

Authors:  Michael W Otto; M Alexandra Kredlow; Jasper A J Smits; Stefan G Hofmann; David F Tolin; Rianne A de Kleine; Agnes van Minnen; A Eden Evins; Mark H Pollack
Journal:  Biol Psychiatry       Date:  2015-09-25       Impact factor: 13.382

Review 4.  Augmentation treatment of psychotherapy for anxiety disorders with D-cycloserine.

Authors:  Stefan G Hofmann; Mark H Pollack; Michael W Otto
Journal:  CNS Drug Rev       Date:  2006 Fall-Winter

Review 5.  Neural mechanisms of extinction learning and retrieval.

Authors:  Gregory J Quirk; Devin Mueller
Journal:  Neuropsychopharmacology       Date:  2007-09-19       Impact factor: 7.853

Review 6.  Pharmacological treatments that facilitate extinction of fear: relevance to psychotherapy.

Authors:  Michael Davis; Karyn M Myers; Jasmeer Chhatwal; Kerry J Ressler
Journal:  NeuroRx       Date:  2006-01

7.  Augmentation of exposure therapy with post-session administration of D-cycloserine.

Authors:  Candyce D Tart; Pamela R Handelsman; Lindsey B Deboer; David Rosenfield; Mark H Pollack; Stefan G Hofmann; Mark B Powers; Michael W Otto; Jasper A J Smits
Journal:  J Psychiatr Res       Date:  2012-10-23       Impact factor: 4.791

Review 8.  Neural mechanisms of pain and alcohol dependence.

Authors:  A Vania Apkarian; Volker Neugebauer; George Koob; Scott Edwards; Jon D Levine; Luiz Ferrari; Mark Egli; Soundar Regunathan
Journal:  Pharmacol Biochem Behav       Date:  2013-10-02       Impact factor: 3.533

9.  Effects of D-cycloserine on extinction and reconditioning of ethanol-seeking behavior in mice.

Authors:  Peter A Groblewski; K Matthew Lattal; Christopher L Cunningham
Journal:  Alcohol Clin Exp Res       Date:  2009-03-06       Impact factor: 3.455

Review 10.  Comparison of combined psycho- and pharmacotherapy with monotherapy in anxiety disorders: controversial viewpoints and clinical perspectives.

Authors:  P Zwanzger; J Diemer; B Jabs
Journal:  J Neural Transm (Vienna)       Date:  2008-09-23       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.